PMC:7088323 / 12650-14023 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T48","span":{"begin":1152,"end":1167},"obj":"Body_part"},{"id":"T49","span":{"begin":1301,"end":1317},"obj":"Body_part"}],"attributes":[{"id":"A48","pred":"fma_id","subj":"T48","obj":"http://purl.org/sig/ont/fma/fma7371"},{"id":"A49","pred":"fma_id","subj":"T49","obj":"http://purl.org/sig/ont/fma/fma7333"}],"text":"Pleural changes including pleural thickening (Fig. 4a) and pleural effusion were reported in COVID-19, among which, the former sign is more prevalent [18]. According to a recent study comprising 81 patients with COVID-19, 32% of them demonstrated pleural thickening while 5% showed pleural effusion [12, 18]. Based on the experience of Middle East respiratory syndrome coronavirus (MERS-­CoV) infection and recent findings [18, 23], the presence of pleural effusion may suggest a poor prognosis in COVID-19. Moreover, the recent autopsy report also revealed a photo of pleural thickening with extensive adhesion in a COVID-19 patient [31], suggesting consistency between CT imaging presentations and autopsy findings.\nFig. 4 a An 80-year-old female COVID-19 patient presenting fever for 7 days. CT scan shows left pleural thickening (white arrows). b A 43-year-old female COVID-19 patient presenting fever and chills for 5 days. CT scan shows subpleural lines (white arrows) in bilateral lower lobes. c A 66-year-old female COVID-19 patient presenting cough and myalgia for 7 days. CT scan shows bilateral GGO and fibrous stripes (white arrows) in the left lower lobe. d A 35-year-old male COVID-19 patient presenting fever and headache for 1 day. CT scan shows a large area of GGO (red frame) in the right upper lobe with multiple small vascular enlargement (white arrows)"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T31","span":{"begin":59,"end":75},"obj":"Body_part"},{"id":"T32","span":{"begin":282,"end":298},"obj":"Body_part"},{"id":"T33","span":{"begin":449,"end":465},"obj":"Body_part"},{"id":"T34","span":{"begin":1163,"end":1167},"obj":"Body_part"},{"id":"T35","span":{"begin":1313,"end":1317},"obj":"Body_part"}],"attributes":[{"id":"A31","pred":"uberon_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/UBERON_0000175"},{"id":"A32","pred":"uberon_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/UBERON_0000175"},{"id":"A33","pred":"uberon_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/UBERON_0000175"},{"id":"A34","pred":"uberon_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"},{"id":"A35","pred":"uberon_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"}],"text":"Pleural changes including pleural thickening (Fig. 4a) and pleural effusion were reported in COVID-19, among which, the former sign is more prevalent [18]. According to a recent study comprising 81 patients with COVID-19, 32% of them demonstrated pleural thickening while 5% showed pleural effusion [12, 18]. Based on the experience of Middle East respiratory syndrome coronavirus (MERS-­CoV) infection and recent findings [18, 23], the presence of pleural effusion may suggest a poor prognosis in COVID-19. Moreover, the recent autopsy report also revealed a photo of pleural thickening with extensive adhesion in a COVID-19 patient [31], suggesting consistency between CT imaging presentations and autopsy findings.\nFig. 4 a An 80-year-old female COVID-19 patient presenting fever for 7 days. CT scan shows left pleural thickening (white arrows). b A 43-year-old female COVID-19 patient presenting fever and chills for 5 days. CT scan shows subpleural lines (white arrows) in bilateral lower lobes. c A 66-year-old female COVID-19 patient presenting cough and myalgia for 7 days. CT scan shows bilateral GGO and fibrous stripes (white arrows) in the left lower lobe. d A 35-year-old male COVID-19 patient presenting fever and headache for 1 day. CT scan shows a large area of GGO (red frame) in the right upper lobe with multiple small vascular enlargement (white arrows)"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T70","span":{"begin":93,"end":101},"obj":"Disease"},{"id":"T71","span":{"begin":212,"end":220},"obj":"Disease"},{"id":"T72","span":{"begin":393,"end":402},"obj":"Disease"},{"id":"T73","span":{"begin":498,"end":506},"obj":"Disease"},{"id":"T74","span":{"begin":617,"end":625},"obj":"Disease"},{"id":"T75","span":{"begin":749,"end":757},"obj":"Disease"},{"id":"T76","span":{"begin":872,"end":880},"obj":"Disease"},{"id":"T77","span":{"begin":1024,"end":1032},"obj":"Disease"},{"id":"T78","span":{"begin":1190,"end":1198},"obj":"Disease"}],"attributes":[{"id":"A70","pred":"mondo_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A71","pred":"mondo_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A74","pred":"mondo_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A75","pred":"mondo_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A76","pred":"mondo_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A77","pred":"mondo_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Pleural changes including pleural thickening (Fig. 4a) and pleural effusion were reported in COVID-19, among which, the former sign is more prevalent [18]. According to a recent study comprising 81 patients with COVID-19, 32% of them demonstrated pleural thickening while 5% showed pleural effusion [12, 18]. Based on the experience of Middle East respiratory syndrome coronavirus (MERS-­CoV) infection and recent findings [18, 23], the presence of pleural effusion may suggest a poor prognosis in COVID-19. Moreover, the recent autopsy report also revealed a photo of pleural thickening with extensive adhesion in a COVID-19 patient [31], suggesting consistency between CT imaging presentations and autopsy findings.\nFig. 4 a An 80-year-old female COVID-19 patient presenting fever for 7 days. CT scan shows left pleural thickening (white arrows). b A 43-year-old female COVID-19 patient presenting fever and chills for 5 days. CT scan shows subpleural lines (white arrows) in bilateral lower lobes. c A 66-year-old female COVID-19 patient presenting cough and myalgia for 7 days. CT scan shows bilateral GGO and fibrous stripes (white arrows) in the left lower lobe. d A 35-year-old male COVID-19 patient presenting fever and headache for 1 day. CT scan shows a large area of GGO (red frame) in the right upper lobe with multiple small vascular enlargement (white arrows)"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T140","span":{"begin":59,"end":75},"obj":"http://purl.obolibrary.org/obo/UBERON_0000175"},{"id":"T141","span":{"begin":151,"end":153},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T142","span":{"begin":169,"end":170},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T143","span":{"begin":282,"end":298},"obj":"http://purl.obolibrary.org/obo/UBERON_0000175"},{"id":"T144","span":{"begin":304,"end":306},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T145","span":{"begin":424,"end":426},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T146","span":{"begin":449,"end":465},"obj":"http://purl.obolibrary.org/obo/UBERON_0000175"},{"id":"T147","span":{"begin":478,"end":479},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T148","span":{"begin":558,"end":559},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T149","span":{"begin":615,"end":616},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T150","span":{"begin":725,"end":726},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T151","span":{"begin":742,"end":748},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"},{"id":"T152","span":{"begin":849,"end":850},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T153","span":{"begin":851,"end":852},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T154","span":{"begin":865,"end":871},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"},{"id":"T155","span":{"begin":1003,"end":1004},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T156","span":{"begin":1017,"end":1023},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"},{"id":"T157","span":{"begin":1169,"end":1172},"obj":"http://www.ebi.ac.uk/efo/EFO_0000265"},{"id":"T158","span":{"begin":1173,"end":1175},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T159","span":{"begin":1185,"end":1189},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T160","span":{"begin":1185,"end":1189},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T161","span":{"begin":1262,"end":1263},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Pleural changes including pleural thickening (Fig. 4a) and pleural effusion were reported in COVID-19, among which, the former sign is more prevalent [18]. According to a recent study comprising 81 patients with COVID-19, 32% of them demonstrated pleural thickening while 5% showed pleural effusion [12, 18]. Based on the experience of Middle East respiratory syndrome coronavirus (MERS-­CoV) infection and recent findings [18, 23], the presence of pleural effusion may suggest a poor prognosis in COVID-19. Moreover, the recent autopsy report also revealed a photo of pleural thickening with extensive adhesion in a COVID-19 patient [31], suggesting consistency between CT imaging presentations and autopsy findings.\nFig. 4 a An 80-year-old female COVID-19 patient presenting fever for 7 days. CT scan shows left pleural thickening (white arrows). b A 43-year-old female COVID-19 patient presenting fever and chills for 5 days. CT scan shows subpleural lines (white arrows) in bilateral lower lobes. c A 66-year-old female COVID-19 patient presenting cough and myalgia for 7 days. CT scan shows bilateral GGO and fibrous stripes (white arrows) in the left lower lobe. d A 35-year-old male COVID-19 patient presenting fever and headache for 1 day. CT scan shows a large area of GGO (red frame) in the right upper lobe with multiple small vascular enlargement (white arrows)"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T12","span":{"begin":1185,"end":1189},"obj":"Chemical"}],"attributes":[{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_30780"}],"text":"Pleural changes including pleural thickening (Fig. 4a) and pleural effusion were reported in COVID-19, among which, the former sign is more prevalent [18]. According to a recent study comprising 81 patients with COVID-19, 32% of them demonstrated pleural thickening while 5% showed pleural effusion [12, 18]. Based on the experience of Middle East respiratory syndrome coronavirus (MERS-­CoV) infection and recent findings [18, 23], the presence of pleural effusion may suggest a poor prognosis in COVID-19. Moreover, the recent autopsy report also revealed a photo of pleural thickening with extensive adhesion in a COVID-19 patient [31], suggesting consistency between CT imaging presentations and autopsy findings.\nFig. 4 a An 80-year-old female COVID-19 patient presenting fever for 7 days. CT scan shows left pleural thickening (white arrows). b A 43-year-old female COVID-19 patient presenting fever and chills for 5 days. CT scan shows subpleural lines (white arrows) in bilateral lower lobes. c A 66-year-old female COVID-19 patient presenting cough and myalgia for 7 days. CT scan shows bilateral GGO and fibrous stripes (white arrows) in the left lower lobe. d A 35-year-old male COVID-19 patient presenting fever and headache for 1 day. CT scan shows a large area of GGO (red frame) in the right upper lobe with multiple small vascular enlargement (white arrows)"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T28","span":{"begin":26,"end":44},"obj":"Phenotype"},{"id":"T29","span":{"begin":59,"end":75},"obj":"Phenotype"},{"id":"T30","span":{"begin":247,"end":265},"obj":"Phenotype"},{"id":"T31","span":{"begin":282,"end":298},"obj":"Phenotype"},{"id":"T32","span":{"begin":449,"end":465},"obj":"Phenotype"},{"id":"T33","span":{"begin":569,"end":587},"obj":"Phenotype"},{"id":"T34","span":{"begin":777,"end":782},"obj":"Phenotype"},{"id":"T35","span":{"begin":814,"end":832},"obj":"Phenotype"},{"id":"T36","span":{"begin":900,"end":905},"obj":"Phenotype"},{"id":"T37","span":{"begin":910,"end":916},"obj":"Phenotype"},{"id":"T38","span":{"begin":1052,"end":1057},"obj":"Phenotype"},{"id":"T39","span":{"begin":1062,"end":1069},"obj":"Phenotype"},{"id":"T40","span":{"begin":1218,"end":1223},"obj":"Phenotype"},{"id":"T41","span":{"begin":1228,"end":1236},"obj":"Phenotype"}],"attributes":[{"id":"A28","pred":"hp_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/HP_0031944"},{"id":"A29","pred":"hp_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/HP_0002202"},{"id":"A30","pred":"hp_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/HP_0031944"},{"id":"A31","pred":"hp_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/HP_0002202"},{"id":"A32","pred":"hp_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/HP_0002202"},{"id":"A33","pred":"hp_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/HP_0031944"},{"id":"A34","pred":"hp_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A35","pred":"hp_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/HP_0031944"},{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A37","pred":"hp_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/HP_0025143"},{"id":"A38","pred":"hp_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A39","pred":"hp_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/HP_0003326"},{"id":"A40","pred":"hp_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A41","pred":"hp_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/HP_0002315"}],"text":"Pleural changes including pleural thickening (Fig. 4a) and pleural effusion were reported in COVID-19, among which, the former sign is more prevalent [18]. According to a recent study comprising 81 patients with COVID-19, 32% of them demonstrated pleural thickening while 5% showed pleural effusion [12, 18]. Based on the experience of Middle East respiratory syndrome coronavirus (MERS-­CoV) infection and recent findings [18, 23], the presence of pleural effusion may suggest a poor prognosis in COVID-19. Moreover, the recent autopsy report also revealed a photo of pleural thickening with extensive adhesion in a COVID-19 patient [31], suggesting consistency between CT imaging presentations and autopsy findings.\nFig. 4 a An 80-year-old female COVID-19 patient presenting fever for 7 days. CT scan shows left pleural thickening (white arrows). b A 43-year-old female COVID-19 patient presenting fever and chills for 5 days. CT scan shows subpleural lines (white arrows) in bilateral lower lobes. c A 66-year-old female COVID-19 patient presenting cough and myalgia for 7 days. CT scan shows bilateral GGO and fibrous stripes (white arrows) in the left lower lobe. d A 35-year-old male COVID-19 patient presenting fever and headache for 1 day. CT scan shows a large area of GGO (red frame) in the right upper lobe with multiple small vascular enlargement (white arrows)"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T88","span":{"begin":0,"end":155},"obj":"Sentence"},{"id":"T89","span":{"begin":156,"end":308},"obj":"Sentence"},{"id":"T90","span":{"begin":309,"end":507},"obj":"Sentence"},{"id":"T91","span":{"begin":508,"end":717},"obj":"Sentence"},{"id":"T92","span":{"begin":718,"end":794},"obj":"Sentence"},{"id":"T93","span":{"begin":795,"end":928},"obj":"Sentence"},{"id":"T94","span":{"begin":929,"end":1081},"obj":"Sentence"},{"id":"T95","span":{"begin":1082,"end":1247},"obj":"Sentence"},{"id":"T96","span":{"begin":1248,"end":1373},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Pleural changes including pleural thickening (Fig. 4a) and pleural effusion were reported in COVID-19, among which, the former sign is more prevalent [18]. According to a recent study comprising 81 patients with COVID-19, 32% of them demonstrated pleural thickening while 5% showed pleural effusion [12, 18]. Based on the experience of Middle East respiratory syndrome coronavirus (MERS-­CoV) infection and recent findings [18, 23], the presence of pleural effusion may suggest a poor prognosis in COVID-19. Moreover, the recent autopsy report also revealed a photo of pleural thickening with extensive adhesion in a COVID-19 patient [31], suggesting consistency between CT imaging presentations and autopsy findings.\nFig. 4 a An 80-year-old female COVID-19 patient presenting fever for 7 days. CT scan shows left pleural thickening (white arrows). b A 43-year-old female COVID-19 patient presenting fever and chills for 5 days. CT scan shows subpleural lines (white arrows) in bilateral lower lobes. c A 66-year-old female COVID-19 patient presenting cough and myalgia for 7 days. CT scan shows bilateral GGO and fibrous stripes (white arrows) in the left lower lobe. d A 35-year-old male COVID-19 patient presenting fever and headache for 1 day. CT scan shows a large area of GGO (red frame) in the right upper lobe with multiple small vascular enlargement (white arrows)"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"228","span":{"begin":758,"end":765},"obj":"Species"},{"id":"229","span":{"begin":881,"end":888},"obj":"Species"},{"id":"230","span":{"begin":1033,"end":1040},"obj":"Species"},{"id":"231","span":{"begin":1199,"end":1206},"obj":"Species"},{"id":"232","span":{"begin":749,"end":757},"obj":"Disease"},{"id":"233","span":{"begin":777,"end":782},"obj":"Disease"},{"id":"234","span":{"begin":872,"end":880},"obj":"Disease"},{"id":"235","span":{"begin":900,"end":905},"obj":"Disease"},{"id":"236","span":{"begin":1024,"end":1032},"obj":"Disease"},{"id":"237","span":{"begin":1052,"end":1057},"obj":"Disease"},{"id":"238","span":{"begin":1062,"end":1069},"obj":"Disease"},{"id":"239","span":{"begin":1190,"end":1198},"obj":"Disease"},{"id":"240","span":{"begin":1218,"end":1223},"obj":"Disease"},{"id":"241","span":{"begin":1228,"end":1236},"obj":"Disease"},{"id":"253","span":{"begin":198,"end":206},"obj":"Species"},{"id":"254","span":{"begin":336,"end":392},"obj":"Species"},{"id":"255","span":{"begin":626,"end":633},"obj":"Species"},{"id":"256","span":{"begin":59,"end":75},"obj":"Disease"},{"id":"257","span":{"begin":93,"end":101},"obj":"Disease"},{"id":"258","span":{"begin":212,"end":220},"obj":"Disease"},{"id":"259","span":{"begin":282,"end":298},"obj":"Disease"},{"id":"260","span":{"begin":393,"end":402},"obj":"Disease"},{"id":"261","span":{"begin":449,"end":465},"obj":"Disease"},{"id":"262","span":{"begin":498,"end":506},"obj":"Disease"},{"id":"263","span":{"begin":617,"end":625},"obj":"Disease"}],"attributes":[{"id":"A228","pred":"tao:has_database_id","subj":"228","obj":"Tax:9606"},{"id":"A229","pred":"tao:has_database_id","subj":"229","obj":"Tax:9606"},{"id":"A230","pred":"tao:has_database_id","subj":"230","obj":"Tax:9606"},{"id":"A231","pred":"tao:has_database_id","subj":"231","obj":"Tax:9606"},{"id":"A232","pred":"tao:has_database_id","subj":"232","obj":"MESH:C000657245"},{"id":"A233","pred":"tao:has_database_id","subj":"233","obj":"MESH:D005334"},{"id":"A234","pred":"tao:has_database_id","subj":"234","obj":"MESH:C000657245"},{"id":"A235","pred":"tao:has_database_id","subj":"235","obj":"MESH:D005334"},{"id":"A236","pred":"tao:has_database_id","subj":"236","obj":"MESH:C000657245"},{"id":"A237","pred":"tao:has_database_id","subj":"237","obj":"MESH:D003371"},{"id":"A238","pred":"tao:has_database_id","subj":"238","obj":"MESH:D063806"},{"id":"A239","pred":"tao:has_database_id","subj":"239","obj":"MESH:C000657245"},{"id":"A240","pred":"tao:has_database_id","subj":"240","obj":"MESH:D005334"},{"id":"A241","pred":"tao:has_database_id","subj":"241","obj":"MESH:D006261"},{"id":"A253","pred":"tao:has_database_id","subj":"253","obj":"Tax:9606"},{"id":"A254","pred":"tao:has_database_id","subj":"254","obj":"Tax:1335626"},{"id":"A255","pred":"tao:has_database_id","subj":"255","obj":"Tax:9606"},{"id":"A256","pred":"tao:has_database_id","subj":"256","obj":"MESH:D010996"},{"id":"A257","pred":"tao:has_database_id","subj":"257","obj":"MESH:C000657245"},{"id":"A258","pred":"tao:has_database_id","subj":"258","obj":"MESH:C000657245"},{"id":"A259","pred":"tao:has_database_id","subj":"259","obj":"MESH:D010996"},{"id":"A260","pred":"tao:has_database_id","subj":"260","obj":"MESH:D007239"},{"id":"A261","pred":"tao:has_database_id","subj":"261","obj":"MESH:D010996"},{"id":"A262","pred":"tao:has_database_id","subj":"262","obj":"MESH:C000657245"},{"id":"A263","pred":"tao:has_database_id","subj":"263","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Pleural changes including pleural thickening (Fig. 4a) and pleural effusion were reported in COVID-19, among which, the former sign is more prevalent [18]. According to a recent study comprising 81 patients with COVID-19, 32% of them demonstrated pleural thickening while 5% showed pleural effusion [12, 18]. Based on the experience of Middle East respiratory syndrome coronavirus (MERS-­CoV) infection and recent findings [18, 23], the presence of pleural effusion may suggest a poor prognosis in COVID-19. Moreover, the recent autopsy report also revealed a photo of pleural thickening with extensive adhesion in a COVID-19 patient [31], suggesting consistency between CT imaging presentations and autopsy findings.\nFig. 4 a An 80-year-old female COVID-19 patient presenting fever for 7 days. CT scan shows left pleural thickening (white arrows). b A 43-year-old female COVID-19 patient presenting fever and chills for 5 days. CT scan shows subpleural lines (white arrows) in bilateral lower lobes. c A 66-year-old female COVID-19 patient presenting cough and myalgia for 7 days. CT scan shows bilateral GGO and fibrous stripes (white arrows) in the left lower lobe. d A 35-year-old male COVID-19 patient presenting fever and headache for 1 day. CT scan shows a large area of GGO (red frame) in the right upper lobe with multiple small vascular enlargement (white arrows)"}